ArticleOsteoarthritis and cartilage open2022

Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status?

M A Karsdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.